vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.
AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $49.9M, roughly 1.6× MARAVAI LIFESCIENCES HOLDINGS, INC.). AMERISAFE INC runs the higher net margin — 10.2% vs -71.6%, a 81.7% gap on every dollar of revenue. On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs -11.8%). Over the past eight quarters, AMERISAFE INC's revenue compounded faster (2.8% CAGR vs -11.9%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
AMSF vs MRVI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $49.9M |
| Net Profit | $8.1M | $-35.7M |
| Gross Margin | — | 25.8% |
| Operating Margin | — | -117.9% |
| Net Margin | 10.2% | -71.6% |
| Revenue YoY | 10.3% | -11.8% |
| Net Profit YoY | -9.0% | -37.7% |
| EPS (diluted) | $0.43 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $49.9M | ||
| Q3 25 | $82.0M | $41.6M | ||
| Q2 25 | $81.1M | $47.4M | ||
| Q1 25 | $72.6M | $46.9M | ||
| Q4 24 | $74.0M | $56.6M | ||
| Q3 24 | $78.7M | $69.0M | ||
| Q2 24 | $75.8M | $69.4M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | $-35.7M | ||
| Q3 25 | $13.8M | $-25.6M | ||
| Q2 25 | $14.0M | $-39.6M | ||
| Q1 25 | $8.9M | $-29.9M | ||
| Q4 24 | $13.2M | $-25.9M | ||
| Q3 24 | $14.3M | $-97.1M | ||
| Q2 24 | $11.0M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.8% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 46.7% | ||
| Q2 24 | — | 44.4% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | -117.9% | ||
| Q3 25 | 21.3% | -98.6% | ||
| Q2 25 | 21.5% | -139.8% | ||
| Q1 25 | 15.5% | -104.9% | ||
| Q4 24 | 22.7% | -66.7% | ||
| Q3 24 | 22.6% | -239.9% | ||
| Q2 24 | 18.1% | -19.4% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | -71.6% | ||
| Q3 25 | 16.9% | -61.4% | ||
| Q2 25 | 17.2% | -83.5% | ||
| Q1 25 | 12.3% | -63.9% | ||
| Q4 24 | 17.8% | -45.8% | ||
| Q3 24 | 18.2% | -140.6% | ||
| Q2 24 | 14.5% | -14.1% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $-0.24 | ||
| Q3 25 | $0.72 | $-0.18 | ||
| Q2 25 | $0.73 | $-0.27 | ||
| Q1 25 | $0.47 | $-0.21 | ||
| Q4 24 | $0.69 | $-0.21 | ||
| Q3 24 | $0.75 | $-0.68 | ||
| Q2 24 | $0.57 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $216.9M |
| Total DebtLower is stronger | — | $291.8M |
| Stockholders' EquityBook value | $246.6M | $212.4M |
| Total Assets | — | $770.6M |
| Debt / EquityLower = less leverage | — | 1.37× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | $216.9M | ||
| Q3 25 | $54.7M | $243.6M | ||
| Q2 25 | $48.5M | $269.9M | ||
| Q1 25 | $44.8M | $285.1M | ||
| Q4 24 | $44.1M | $322.4M | ||
| Q3 24 | $63.7M | $578.2M | ||
| Q2 24 | $30.6M | $573.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $291.8M | ||
| Q3 25 | — | $292.8M | ||
| Q2 25 | — | $293.9M | ||
| Q1 25 | — | $294.9M | ||
| Q4 24 | — | $295.9M | ||
| Q3 24 | — | $521.7M | ||
| Q2 24 | — | $522.5M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $212.4M | ||
| Q3 25 | $274.8M | $245.4M | ||
| Q2 25 | $265.6M | $265.9M | ||
| Q1 25 | $260.8M | $300.6M | ||
| Q4 24 | $257.3M | $325.3M | ||
| Q3 24 | $314.4M | $344.9M | ||
| Q2 24 | $301.0M | $434.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $770.6M | ||
| Q3 25 | $1.2B | $849.2M | ||
| Q2 25 | $1.2B | $897.0M | ||
| Q1 25 | $1.2B | $959.8M | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.2B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-22.8M |
| Free Cash FlowOCF − Capex | — | $-24.9M |
| FCF MarginFCF / Revenue | — | -49.9% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $-22.8M | ||
| Q3 25 | $10.7M | $-15.2M | ||
| Q2 25 | $-8.4M | $-10.3M | ||
| Q1 25 | $-1.8M | $-9.4M | ||
| Q4 24 | $24.2M | $-14.6M | ||
| Q3 24 | $8.4M | $13.1M | ||
| Q2 24 | $-2.6M | $17.4M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $-24.9M | ||
| Q3 25 | $9.8M | $-18.1M | ||
| Q2 25 | $-9.5M | $-13.1M | ||
| Q1 25 | $-1.8M | $-14.6M | ||
| Q4 24 | $23.4M | $-20.5M | ||
| Q3 24 | $8.4M | $4.5M | ||
| Q2 24 | $-2.6M | $7.9M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | -49.9% | ||
| Q3 25 | 11.9% | -43.4% | ||
| Q2 25 | -11.7% | -27.7% | ||
| Q1 25 | -2.5% | -31.2% | ||
| Q4 24 | 31.5% | -36.2% | ||
| Q3 24 | 10.7% | 6.6% | ||
| Q2 24 | -3.5% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 4.2% | ||
| Q3 25 | 1.1% | 7.0% | ||
| Q2 25 | 1.3% | 6.1% | ||
| Q1 25 | 0.0% | 11.2% | ||
| Q4 24 | 1.1% | 10.3% | ||
| Q3 24 | 0.0% | 12.4% | ||
| Q2 24 | 0.1% | 13.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | -0.61× | — | ||
| Q1 25 | -0.20× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 0.59× | — | ||
| Q2 24 | -0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSF
Segment breakdown not available.
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
